Safety and preliminary efficacy of intrathecal (IT) and intravenous (IV) nivolumab (N) for patients (pts) with leptomeningeal disease (LMD)

被引：0
|
作者：
Glitza, Isabella Claudia
John, Ida
Phillips, Suzanne
See, Lauren
Bassett, Roland L.
Lin, Ruitao
Rohlfs, Michelle L.
Richard, Jessie
Iqbal, Masood
Hennegan, Tarin
McCutcheon, Ian E.
Ferguson, Sherise D.
Morad, Golnaz
O'Brien, Barbara Jane
Tummala, Sudhakar
Guha-Thakurta, Nandita
Debnam, Matthew
Tawbi, Hussein A.
Burton, Elizabeth M.
Davies, Michael A.
机构：
[1] Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] UT MD Anderson Canc Ctr, Houston, TX USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9554
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for melanoma (MM) patients (pts) with leptomeningeal disease (LMD)
    Glitza, I. C.
    Phillips, S.
    John, I.
    Bassett, R. L.
    Lin, R.
    Rohlfs, M. L.
    Richard, J.
    Iqbal, M.
    Hennegan, T.
    McCutcheon, I. E.
    Ferguson, S.
    O'Brien, B.
    Tummala, S.
    Guha-Thakurta, N.
    Debnam, M.
    Tawbi, H. A.
    Burton, E.
    Davies, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S652 - S652
  • [2] Intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD).
    John, Ida
    Foster, Alexandra P.
    Haymaker, Cara L.
    Bassett, Roland L.
    Lee, J. Jack
    Rohlfs, Michelle L.
    Richard, Jessie
    Iqbal, Masood
    McCutcheon, Ian E.
    Ferguson, Sherise D.
    Heimberger, Amy B.
    Saberian, Chantal M.
    O'Brien, Barbara Jane
    Tummala, Sudhakar
    Guha-Thakurta, Nandita
    Debnam, Matthew
    Tawbi, Hussein Abdul-Hassan
    Burton, Elizabeth M.
    Davies, Michael A.
    Glitza, Isabella Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)
    Glitza, I. C.
    Rohlfs, M. L.
    Iqbal, M.
    Richard, J.
    Burton, E.
    Duncan, S.
    Brown, C.
    Anderson, J.
    Hwu, P.
    Hwu, W-J.
    Wong, M.
    Yee, C.
    Patel, S.
    Woodman, S.
    Amaria, R.
    Diab, A.
    Tawbi, H.
    Davies, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [4] Single-center phase I/Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD).
    Glitza, Isabella Claudia
    Phillips, Suzanne
    Brown, Courtney
    Haymaker, Cara L.
    Bassett, Roland L.
    Lee, J. Jack
    Rohlfs, Michelle L.
    Richard, Jessie
    Iqbal, Masood
    John, Ida
    McCutcheon, Ian E.
    Ferguson, Sherise D.
    Heimberger, Amy B.
    O'Brien, Barbara Jane
    Tummala, Sudhakar
    Guha-Thakurta, Nandita
    Debnam, Matthew
    Burton, Elizabeth M.
    Tawbi, Hussein Abdul-Hassan
    Davies, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N)
    Morad, Golnaz
    Yang, Yitao
    Duncan, Sheila
    Ferguson, Sherise D.
    Wargo, Jennifer Ann
    Burton, Elizabeth M.
    Tawbi, Hussein A.
    Davies, Michael A.
    Liang, Han
    Glitza, Isabella Claudia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Long-term efficacy of intrathecal interleukin-2 (IT IL2) in metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD)
    Glitza, I. C.
    Rohlfs, M. L.
    Bassett, R., Jr.
    John, I.
    Richard, J.
    Iqbal, M.
    Bernzen, T.
    Gerber, D. L.
    Lacey, C.
    Diab, A.
    Amaria, R. N.
    Woodman, S. E.
    Patel, S. P.
    Yee, C.
    Hwu, W. J.
    Hwu, P.
    Papadopoulos, N.
    Davies, M. A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S109 - S109
  • [7] Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
    Glitza Oliva, Isabella C.
    Ferguson, Sherise D.
    Bassett Jr, Roland
    Foster, Alexandra P.
    John, Ida
    Hennegan, Tarin D.
    Rohlfs, Michelle
    Richard, Jessie
    Iqbal, Masood
    Dett, Tina
    Lacey, Carol
    Jackson, Natalie
    Rodgers, Theresa
    Phillips, Suzanne
    Duncan, Sheila
    Haydu, Lauren
    Lin, Ruitao
    Amaria, Rodabe N.
    Wong, Michael K.
    Diab, Adi
    Yee, Cassian
    Patel, Sapna P.
    McQuade, Jennifer L.
    Fischer, Grant M.
    McCutcheon, Ian E.
    O'Brien, Barbara J.
    Tummala, Sudhakar
    Debnam, Matthew
    Guha-Thakurta, Nandita
    Wargo, Jennifer A.
    Burton, Elizabeth M.
    Tawbi, Hussein A.
    Davies, Michael A.
    NATURE MEDICINE, 2023, 29 (04) : 898 - 905
  • [8] Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
    Isabella C. Glitza Oliva
    Sherise D. Ferguson
    Roland Bassett
    Alexandra P. Foster
    Ida John
    Tarin D. Hennegan
    Michelle Rohlfs
    Jessie Richard
    Masood Iqbal
    Tina Dett
    Carol Lacey
    Natalie Jackson
    Theresa Rodgers
    Suzanne Phillips
    Sheila Duncan
    Lauren Haydu
    Ruitao Lin
    Rodabe N. Amaria
    Michael K. Wong
    Adi Diab
    Cassian Yee
    Sapna P. Patel
    Jennifer L. McQuade
    Grant M. Fischer
    Ian E. McCutcheon
    Barbara J. O’Brien
    Sudhakar Tummala
    Matthew Debnam
    Nandita Guha-Thakurta
    Jennifer A. Wargo
    Fernando C. L. Carapeto
    Courtney W. Hudgens
    Jason T. Huse
    Michael T. Tetzlaff
    Elizabeth M. Burton
    Hussein A. Tawbi
    Michael A. Davies
    Nature Medicine, 2023, 29 : 898 - 905
  • [9] Leptomeningeal disease (LMD) in patients (pts) with metastatic melanoma (MM): Survival analysis of a contemporary cohort
    Glitza, I. C.
    Saberian, C.
    Simon, J.
    Duncan, S.
    Amaria, R.
    Davies, M.
    Diab, A.
    Mcquade, J.
    Patel, S.
    Tawbi, H. A.
    Yee, C.
    Wong, M.
    McCutcheon, I.
    Milton, D.
    Ferguson, S.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S668 - S669
  • [10] Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results (vol 9, pg 898, 2023)
    Glitza Oliva, Isabella C.
    Ferguson, Sherise D.
    Bassett, Roland
    Foster, Alexandra P.
    John, Ida
    Hennegan, Tarin D.
    Rohlfs, Michelle
    Richard, Jessie
    Iqbal, Masood
    Dett, Tina
    Lacey, Carol
    Jackson, Natalie
    Rodgers, Theresa
    Phillips, Suzanne
    Duncan, Sheila
    Haydu, Lauren
    Lin, Ruitao
    Amaria, Rodabe N.
    Wong, Michael K.
    Diab, Adi
    Yee, Cassian
    Patel, Sapna P.
    Mcquade, Jennifer L.
    Fischer, Grant M.
    Mccutcheon, Ian E.
    O'Brien, Barbara J.
    Tummala, Sudhakar
    Debnam, Matthew
    Guha-Thakurta, Nandita
    Wargo, Jennifer A.
    Carapeto, Fernando C. L.
    Hudgens, Courtney W.
    Huse, Jason T.
    Tetzlaff, Michael T.
    Burton, Elizabeth M.
    Tawbi, Hussein A.
    Davies, Michael A.
    NATURE MEDICINE, 2024, 30 (06) : 1787 - 1787
12345